Corteva Inc (CTVA)

Corteva is splitting into TWO publicly-traded companies

This is not the Corteva you knew a year ago. On October 1, 2025, Corteva Inc's (CTVA) board of directors unanimously approved a major corporate separation: the company will split into TWO independent publicly-traded companies by Q4 2026. If you buy CTVA shares today, you are effectively buying a 'stub' that will convert into TWO separate share positions once the separation completes.

The first company, named Vylor Inc., will take over Corteva's Seed & Genetics business, including germplasm, gene editing, hybrid wheat, and biotechnology licensing. Vylor launches with more than 4,000 germplasm patents and more than 2,000 biotech patents, a formidable intellectual property portfolio in the global seed industry.

The second company is the remaining Corteva, which becomes a pure-play Crop Protection company covering agrochemicals, biologicals, and nature-based solutions.

What this means for CTVA shareholders today

The separation is targeted for completion in Q4 2026, with shares distributed via a tax-free pro-rata distribution to existing CTVA shareholders. In practice, anyone holding CTVA shares before the separation date will receive shares in BOTH new entities, Corteva (Crop Protection) AND Vylor (Seed & Genetics), without needing to take any additional action or trigger an immediate tax liability.

Leadership

Chuck Magro, Corteva's current CEO, will move to lead Vylor as CEO after separation. Meanwhile, the remaining Corteva (Crop Protection) will be led by an external hire, Luke Kissam, former Chairman, President and CEO of Albemarle. This signals that both new entities are considered substantial enough to each warrant a fully separate, dedicated leadership team.

Segment revenue mix

In full-year 2025, the Seed segment posted net sales of $9.90 billion (up 4% YoY) with operating EBITDA of $2.64 billion (up 19%), while the Crop Protection segment posted net sales of $7.50 billion (up 2%) with operating EBITDA of $1.35 billion (up 6%). This means the Seed business that will become Vylor is actually larger AND more profitable (higher EBITDA margin) than the Crop Protection segment that stays under the Corteva name.

Shariah compliance status

Per Zoya's screening, CTVA is confirmed SHARIAH COMPLIANT. The company's balance sheet carries low leverage (debt-to-equity of just 0.17x), consistent with Shariah compliant debt-ratio thresholds. However, the standalone Shariah status of Corteva and Vylor as SEPARATE entities post-split has not yet been formally confirmed, so investors should re-check the Shariah status of both new entities once the separation completes.

This section is being refreshed with the latest figures. Please check back soon.

This section is being refreshed with the latest figures. Please check back soon.